Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease.

MLA

Yang, Han, et al. “Mesenchymal Stem Cell-Based Therapy for Autoimmune-Related Fibrotic Skin Diseases—systemic Sclerosis and Sclerodermatous Graft-versus-Host Disease.” Stem Cell Research & Therapy, vol. 14, no. 1, Dec. 2023, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13287-023-03543-w.

APA

Yang, H., Cheong, S., He, Y., & Lu, F. (2023). Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease. Stem Cell Research & Therapy, 14(1), 1–18. https://doi.org/10.1186/s13287-023-03543-w

Chicago

Yang, Han, Sousan Cheong, Yunfan He, and Feng Lu. 2023. “Mesenchymal Stem Cell-Based Therapy for Autoimmune-Related Fibrotic Skin Diseases—systemic Sclerosis and Sclerodermatous Graft-versus-Host Disease.” Stem Cell Research & Therapy 14 (1): 1–18. doi:10.1186/s13287-023-03543-w.